Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates
Carrie E. McCurdy, … , Jacob E. Friedman, Kevin L. Grove
Carrie E. McCurdy, … , Jacob E. Friedman, Kevin L. Grove
Published January 19, 2009
Citation Information: J Clin Invest. 2009;119(2):323-335. https://doi.org/10.1172/JCI32661.
View: Text | PDF
Research Article Metabolism

Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates

  • Text
  • PDF
Abstract

Maternal obesity is thought to increase the offspring’s risk of juvenile obesity and metabolic diseases; however, the mechanism(s) whereby excess maternal nutrition affects fetal development remain poorly understood. Here, we investigated in nonhuman primates the effect of chronic high-fat diet (HFD) on the development of fetal metabolic systems. We found that fetal offspring from both lean and obese mothers chronically consuming a HFD had a 3-fold increase in liver triglycerides (TGs). In addition, fetal offspring from HFD-fed mothers (O-HFD) showed increased evidence of hepatic oxidative stress early in the third trimester, consistent with the development of nonalcoholic fatty liver disease (NAFLD). O-HFD animals also exhibited elevated hepatic expression of gluconeogenic enzymes and transcription factors. Furthermore, fetal glycerol levels were 2-fold higher in O-HFD animals than in control fetal offspring and correlated with maternal levels. The increased fetal hepatic TG levels persisted at P180, concurrent with a 2-fold increase in percent body fat. Importantly, reversing the maternal HFD to a low-fat diet during a subsequent pregnancy improved fetal hepatic TG levels and partially normalized gluconeogenic enzyme expression, without changing maternal body weight. These results suggest that a developing fetus is highly vulnerable to excess lipids, independent of maternal diabetes and/or obesity, and that exposure to this may increase the risk of pediatric NAFLD.

Authors

Carrie E. McCurdy, Jacalyn M. Bishop, Sarah M. Williams, Bernadette E. Grayson, M. Susan Smith, Jacob E. Friedman, Kevin L. Grove

×

Figure 5

Maternal diet reversal partially prevents the development of fatty liver in the fetal offspring.

Options: View larger image (or click on image) Download as PowerPoint
Maternal HFD feeding leads to increased expression of genes in the gluco...
(A) Liver TG levels for O-HFY4 and O-HFREV animals. Dashed line represents TG levels in normal control fetal offspring. #P < 0.05 versus O-HFY4 (2-tailed Student’s t test). (B–E) Relative difference in G6P (B), FBP1 (C), PCK1 (D), and PGC1A (E) expression in the fetal liver of control (n = 9), O-HFD (n = 15), and O-HFREV (n = 7) groups. Data were obtained from samples obtained at different times and run in different assays, but were normalized to control samples that were present in every assay. O-HFD values represent the average of both O–HFD-R and O–HFD-S groups from Figure 4. *P < 0.05 versus control (ANOVA with Bonferonni’s multiple comparison test). There was no significant difference between the O-HFREV and either the control or the O-HFD groups.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts